Next generation sequencing

Encefalopatie epilettiche e dello sviluppo: dalla pratica alla genetica, andata e ritorno

Zanus C, Musante L, Faletra F, Carrozzi M, Costa P.

2022/1 — pag. 33-40 — DOI

In the last decades the research on the genetics of epilepsy has greatly expanded, supported by the development of effective next-generation sequencing (NGS) methods. In particular, the studies in Developmental and Epileptic Encephalopathies (DEEs) d...

Il neonato che “sa di sale”

Serra G, Antona V, D’Alessandro M, Corsello G

2021/2 — pag. 119-122 — DOI

Pseudohypoaldosteronism type 1 (PHA1) is a rare genetic disease due to the peripheral resistance to aldosterone. Clinical spectrum with neonatal onset includes salt loss, hyponatremia, hypochloraemia, hyperkalaemia, metabolic acidosis and increased p...

Medicina di precisione: miti e realtà

Amoroso S, Baldo F, Bettini L, Bossini B, Nucera S

2021/1 — pag. 18-24 — DOI

Precision medicine is an emerging framework to maximise therapeutic benefit by modifying individual patients’ treatment considering the variations in their demographic, genomic and environmental factors. The present review describes recent advances, ...

Il bambino con eccesso di crescita tra variabilità clinica ed eterogeneità genetica

G. Serra, M. Schierz, V. Antona, C.F. Giardina, M. Giuffrè, E. Piro, G. Corsello

2020/4 — pag. 243-248

Either in the newborn or in the child overgrowth can be generalized or localized if it is limited to one or more body regions. When overgrowth depends on a metabolic imbalance, or it is constitutional, the excessive growth can be the only clinical si...

Corto come il papà

G. Tornese

2019/7 — pag. 431-437

Familial short stature is the second cause of short stature immediately after constitutional delay of growth and puberty. So far, in case of familiarity for short stature, regular growth velocity, bone age compatible with chronological age, the ind...

Le sfide della Medicina contemporanea

S. Maitz, A. Biondi

2018/10 — pag. 635